Company Filing History:
4 out of 88 
2 out of 236 Years Active: 1997-1999
Title: **Jeff W. Jacobs: Innovator in Peptide Technology**
Introduction
Jeff W. Jacobs, a notable inventor based in San Mateo, California, has made significant contributions to the field of biochemistry, specifically focusing on peptides and their interactions with biological receptors. With a strong portfolio of four patents, Jacobs has established himself as an influential figure in innovative therapeutic approaches.
Latest Patents
Among his most recent patents is the groundbreaking work on "Peptides and Compounds that Bind to the IL-1 Receptor." These innovative peptides are designed to bind to the interleukin-1 type I receptor (IL-1RtI), facilitating assays to measure the presence of IL-1R and its agonists or antagonists. The patent outlines several key sequences of amino acids, exhibiting numerous structural options that enhance the utility of these peptides in therapeutic applications. Each peptide is carefully structured for effectiveness, varying in length between 11 to 40 amino acids, showcasing the versatility and complexity of their design.
Career Highlights
Throughout his career, Jeff Jacobs has worked with notable companies including Affymax Technologies and Hoechst Marion Roussel. His work in these organizations has been pivotal in advancing peptide technology and developing novel therapeutic strategies targeting IL-1 receptors. His experience in industry settings has provided him with a unique insight into the practical applications and commercialization of his inventions.
Collaborations
Collaborative efforts with esteemed colleagues such as Stephen D. Yanofsky and Ronald W. Barrett have allowed Jacobs to expand his research while fostering an environment of innovation. These partnerships have been instrumental in propelling his projects forward and achieving significant milestones in the realm of peptide research.
Conclusion
Jeff W. Jacobs stands out as a prominent inventor in the field of peptide technology. His latest patents reflect a deep understanding of biochemistry and a commitment to innovation, making him a valuable asset to the scientific community. As he continues to explore the potential of peptide-based therapies, his contributions will likely lead to significant advancements in medical treatments.